Lesson plan
IP1867B
IP1867B is a potential brain cancer treatment under development by Innovate Pharmaceuticals for use in the treatment of brain tumors, by combining reformulated aspirin with two additional ingredients, into a soluble form. Developing a true liquid aspirin has long been a scientific goal. This new formulation significantly increases the ability of drugs to cross the blood brain barrier, which serves to protect the brain but also blocks many conventional cancer drugs from reaching brain tumors. This research suggests that Innovate Pharmaceutical's IP1867B could be highly effective against glioblastoma (GBM), one of the most aggressive forms of the disease, which kills thousands of patients within a year. it has only been tested 'in-vitro' on adult and pediatric cancer and nerve cells. Clinical trials are not yet scheduled.
Article summary
IP1867B is a potential brain cancer treatment under development by Innovate Pharmaceuticals for use in the treatment of brain tumors, by combining reformulated aspirin with two additional ingredients, into a soluble form. Developing a true liquid aspirin has long been a scientific goal. This new formulation significantly increases the ability of drugs to cross the blood brain barrier, which serves to protect the brain but also blocks many conventional cancer drugs from reaching brain tumors. This research suggests that Innovate Pharmaceutical's IP1867B could be highly effective against glioblastoma (GBM), one of the most aggressive forms of the disease, which kills thousands of patients within a year. it has only been tested 'in-vitro' on adult and pediatric cancer and nerve cells. Clinical trials are not yet scheduled.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.